Literature DB >> 28444563

889 days of support on hydrodynamic bearing rotation mode of the DuraHeart™ for bridge-to-heart transplantation.

Yorihiko Matsumoto1, Tomoyuki Fujita2, Satsuki Fukushima1, Hiroki Hata1, Yusuke Shimahara1, Yuta Kume1, Kizuku Yamashita1, Kensuke Kuroda3, Seiko Nakajima3, Haruki Sunami3, Takuma Sato3, Osamu Seguchi3, Masanobu Yanase3, Norihide Fukushima3, Junjiro Kobayashi1.   

Abstract

A 49-year-old man with ischemic cardiomyopathy and tricuspid regurgitation underwent a DuraHeart implantation and tricuspid annuloplasty for bridge-to-heart transplantation. On postoperative day 393, the magnetic levitation system suddenly broke down, and the pump system went into hydrodynamic bearing rotation (HD) mode without causing relevant symptoms. The controller was exchanged with one that adapted to the HD mode. No significant hemodynamic changes or indications of hemolysis were observed. On postoperative day 982, the pump temporarily stopped nine times. The patient refused pump exchange despite our strong recommendation for it. After 1283 days of DuraHeart support (889 days in HD mode) without hemolysis or neurologic events, he underwent heart transplantation. The DuraHeart manufacturer's analysis revealed much damage to the insulation and fatigue fractures of the conductors, which had resulted in temporary cessation of function and failure of the magnetic levitation system. This was a rare case of long-term support under the DuraHeart HD mode.

Entities:  

Keywords:  Driveline fracture; DuraHeart; Hydrodynamic bearing rotation mode; LVAD

Mesh:

Year:  2017        PMID: 28444563     DOI: 10.1007/s10047-017-0962-9

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  3 in total

1.  Lessons learned from the first fully magnetically levitated centrifugal LVAD trial in the United States: the DuraHeart trial.

Authors:  Nader Moazami; Robert J Steffen; Yoshifumi Naka; Ulrich Jorde; Stephen Bailey; Srinivas Murali; Margarita T Camacho; Mark Zucker; Philip J Marascalco; Vivek Rao; David Feldman
Journal:  Ann Thorac Surg       Date:  2014-06-10       Impact factor: 4.330

2.  European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system.

Authors:  Michiel Morshuis; Aly El-Banayosy; Latif Arusoglu; Reiner Koerfer; Roland Hetzer; Georg Wieselthaler; Alain Pavie; Chisato Nojiri
Journal:  Eur J Cardiothorac Surg       Date:  2009-02-23       Impact factor: 4.191

3.  DuraHeart™ magnetically levitated left ventricular assist device: Osaka University experience.

Authors:  Taichi Sakaguchi; Goro Matsumiya; Daisuke Yoshioka; Shigeru Miyagawa; Hiroyuki Nishi; Yasushi Yoshikawa; Satsuki Fukushima; Shunsuke Saito; Takayoshi Ueno; Yoshiki Sawa
Journal:  Circ J       Date:  2013-04-18       Impact factor: 2.993

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.